|
|
|
| Solid serous cystadenoma of the pancreas: A rare tumor with challenging differential diagnosis |
| Luca Saragoni a , Carlo Alberto Pacilio b , ∗, Davide Cavaliere b , Francesco Limarzi a , Claudio Isopi b , Giorgio Ercolani b , c |
a Pathology Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via Carlo Forlanini 34, 47121, Forlì, Italy
b General and Oncologic Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via Carlo Forlanini 34, 47121, Forlì, Italy
c Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy
∗ Corresponding author.
E-mail address: carloalberto.pacilio@auslromagna.it (C.A. Pacilio). |
|
|
|
|
Abstract Cystic tumors of the pancreas are rare, accounting for 1%-5% of exocrine pancreatic tumors. Serous cystadenoma (SCA) was firstly described by Compagno and Oertel in 1978 as a benign glycogenrich neoplasm [1]. In 1996 Perez-Ordonez et al. [2] reported the first case of a solid variant of SCA; since then, 23 cases of this extremely uncommon tumor variant were reported. Due to its rarity and unusual imaging appearance, a correct differential diagnosis is difficult and can lead to mistaken diagnosis and unnecessary treatment. According to Surgical CAse REport (SCARE) Guidelines [3], we present the second case of pancreatic solid SCA (SSCA) reported in Italy, the first surgically treated with a robotic approach worldwide.
|
|
|
|
|
|
|
|
|
2022, Vol. 21 
